I had high expectations going into the hot-topics session about the ongoing Senate investigation into pharmaceutical companies' educational grants at the Alliance for CME annual conference — but I left disappointed and concerned about the CME community's lack of response to this extremely important development. (See news story, page 14.)
Register to view the full article
Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.
0 comments
Hide comments
